BioCentury | Dec 2, 2020
Finance

Data Byte: IPO queue picks up post-election

...in a NASDAQ IPO after withdrawing its planned listing in July.On the flipside, immuno-oncology company Compass Therapeutics Inc....
BioCentury | Jun 25, 2020
Deals

June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla

...raises $60M Antibody therapeutics company Compass completed a reverse merger with Olivia Ventures Inc., becoming Compass Therapeutics Inc....
...S. Eaton, Staff Writer Tetraphase Pharmaceuticals Inc. La Jolla Pharmaceutical Co. Melinta Therapeutics Inc. AcelRx Pharmaceuticals Inc. Century Therapeutics LLC Empirica Therapeutics Compass Therapeutics Editas...
BioCentury | Dec 6, 2019
Targets & Mechanisms

Bispecifics and allogeneics steal the spotlight from autologous CAR Ts

...all of the bispecifics discussed are designed to bind T cells. A preclinical study from Compass Therapeutics...
...others each bind two coagulation factors to treat hemophilia. The others include an antibody from Compass Therapeutics...
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...Rare diseases company Enzyvant Sciences GmbH hired Jeb Ledell as COO. He was COO at Compass Therapeutics...
BioCentury | Aug 10, 2019
Company News

Management tracks: Melinta, Editas, Accelerate, Santhera

...of Millendo Therapeutics Inc. (Ann Arbor, Mich.) Tighe was VP, translational immunology and immunopharmacology at Compass Therapeutics...
BioCentury | Jun 7, 2019
Finance

Alexandria parlays growing life sciences real estate holdings into a flurry of VC deals

...example, its deals include the $132 million series A round for cancer and autoimmune company Compass Therapeutics...
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Compass Therapeutics...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...company Allogene Therapeutics Inc., which raised a $300 million series A round; and immunotherapy play Compass Therapeutics...
...of Pennsylvania , Lilly Asia Ventures , Kleiner Perkins Caufield & Byers Preclin Cancer 2015 Compass Therapeutics...
...Cerevel Therapeutics LLC, Boston, Mass. Chroma Therapeutics Ltd., Abingdon, U.K. Columbia University, New York, N.Y. Compass Therapeutics...
BioCentury | Dec 20, 2018
Company News

Management tracks: Prometic, Synlogic

...October after Dan Wechsler stepped down as president, CEO and a board member. Immuno-oncology company Compass Therapeutics...
BioCentury | Nov 9, 2018
Finance

Biomatics’ next phase

...building companies,” said Sunderland, citing his experience co-founding and managing biotechs such as Adimab LLC, Compass Therapeutics...
BioCentury | Nov 9, 2018
Financial News

Biomatics closes second fund at $300M

...Diversified Holdings and has co-founded several biotechs, including antibody discovery companies Adimab LLC (Lebanon, N.H.), Compass Therapeutics...
...Stakes" ). Biomatics Capital Partners, Seattle, Wash. Virginia Li Adimab LLC Alector Inc. AstraZeneca plc Bill & Melinda Gates Foundation Biomatics Capital Compass Therapeutics...
Items per page:
1 - 10 of 16
BioCentury | Dec 2, 2020
Finance

Data Byte: IPO queue picks up post-election

...in a NASDAQ IPO after withdrawing its planned listing in July.On the flipside, immuno-oncology company Compass Therapeutics Inc....
BioCentury | Jun 25, 2020
Deals

June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla

...raises $60M Antibody therapeutics company Compass completed a reverse merger with Olivia Ventures Inc., becoming Compass Therapeutics Inc....
...S. Eaton, Staff Writer Tetraphase Pharmaceuticals Inc. La Jolla Pharmaceutical Co. Melinta Therapeutics Inc. AcelRx Pharmaceuticals Inc. Century Therapeutics LLC Empirica Therapeutics Compass Therapeutics Editas...
BioCentury | Dec 6, 2019
Targets & Mechanisms

Bispecifics and allogeneics steal the spotlight from autologous CAR Ts

...all of the bispecifics discussed are designed to bind T cells. A preclinical study from Compass Therapeutics...
...others each bind two coagulation factors to treat hemophilia. The others include an antibody from Compass Therapeutics...
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...Rare diseases company Enzyvant Sciences GmbH hired Jeb Ledell as COO. He was COO at Compass Therapeutics...
BioCentury | Aug 10, 2019
Company News

Management tracks: Melinta, Editas, Accelerate, Santhera

...of Millendo Therapeutics Inc. (Ann Arbor, Mich.) Tighe was VP, translational immunology and immunopharmacology at Compass Therapeutics...
BioCentury | Jun 7, 2019
Finance

Alexandria parlays growing life sciences real estate holdings into a flurry of VC deals

...example, its deals include the $132 million series A round for cancer and autoimmune company Compass Therapeutics...
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Compass Therapeutics...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...company Allogene Therapeutics Inc., which raised a $300 million series A round; and immunotherapy play Compass Therapeutics...
...of Pennsylvania , Lilly Asia Ventures , Kleiner Perkins Caufield & Byers Preclin Cancer 2015 Compass Therapeutics...
...Cerevel Therapeutics LLC, Boston, Mass. Chroma Therapeutics Ltd., Abingdon, U.K. Columbia University, New York, N.Y. Compass Therapeutics...
BioCentury | Dec 20, 2018
Company News

Management tracks: Prometic, Synlogic

...October after Dan Wechsler stepped down as president, CEO and a board member. Immuno-oncology company Compass Therapeutics...
BioCentury | Nov 9, 2018
Finance

Biomatics’ next phase

...building companies,” said Sunderland, citing his experience co-founding and managing biotechs such as Adimab LLC, Compass Therapeutics...
BioCentury | Nov 9, 2018
Financial News

Biomatics closes second fund at $300M

...Diversified Holdings and has co-founded several biotechs, including antibody discovery companies Adimab LLC (Lebanon, N.H.), Compass Therapeutics...
...Stakes" ). Biomatics Capital Partners, Seattle, Wash. Virginia Li Adimab LLC Alector Inc. AstraZeneca plc Bill & Melinda Gates Foundation Biomatics Capital Compass Therapeutics...
Items per page:
1 - 10 of 16